Table 2.
Outcome | Intervention | Control | P-value2 | P-value3 | ||||
---|---|---|---|---|---|---|---|---|
Baseline (n = 15) |
Postintervention (n = 11) |
P-value1 | Baseline (n = 8) |
Postintervention (n = 7) |
P-value1 | |||
C-reactive protein (mg/L) | 3.95 (2.09 to 5.82) | 3.91 (2.02 to 5.79) | .90 | 6.09 (3.27 to 8.92) | 5.53 (2.70 to 8.36) | .24 | .24 | .37 |
HbA1c percent | 5.85 (5.42 to 6.29) | 5.85 (5.42 to 6.29) | .97 | 5.61 (4.95 to 6.29) | 5.59 (4.93 to 6.26) | .82 | .56 | .54 |
Glucose (mg/dL) | 103 (92 to 115) | 102 (90 to 114) | .77 | 97 (80 to 114) | 101 (84 to 119) | .25 | .58 | .93 |
Body mass index (kg/m2) | 33.3 (29.2 to 37.4) | 33.2 (29.1 to 37.3) | .78 | 33.2 (27.1 to 39.4) | 33.4 (27.2 to 39.5) | .77 | .99 | .97 |
Body fat percent | 39.8 (34.1 to 45.6) | 40.3 (34.5 to 46.0) | .44 | 41.1 (32.4 to 49.9) | 40.4 (31.6 to 49.1) | .29 | .81 | .98 |
Body weight (kg) | 88.5 (78.9 to 98.0) | 88.5 (78.9 to 98.0) | .85 | 93.4 (78.9 to 107.5) | 93.4 (78.9 to 107.5) | .93 | .59 | .59 |
E-DII | 0.07 (–1.29 to 1.43) | –1.24 (–2.67 to 0.18) | .02 | –0.90 (–2.96 to 1.15) | –1.29 (–3.34 to 0.77) | .59 | .45 | .97 |
Values presented are means and (95% confidence intervals). All models adjusted for age. All P-values estimated using repeated measures analyses with group-by-time interactions. P-value1 represents differences within study arm between time points. P-value2 represents differences within baseline across study arms. P-value3 represents differences within postintervention across study arms.
Abbreviations: E-DII, energy-adjusted Dietary Inflammatory Index.